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Abstract
Over the last decade, endoscopic ultrasound-guided biliary drainage (EUS-BD)
has evolved into a widely accepted alternative to the percutaneous approach in
cases of biliary obstruction with failed endoscopic retrograde
cholangiopancreaticography (ERCP). The available evidence suggests that, in
experienced hands, EUS-BD might even replace ERCP as the first-line procedure
in specific situations such as malignant distal bile duct obstruction. The aim of
this review is to summarize the available data on EUS-BD and propose an
evidence-based algorithm clarifies the role of the different EUS-BD techniques in
the management of benign and malignant biliary obstructive disease.
Key words: Endoscopic ultrasound; Endoscopic retrograde cholangiopancreaticography;
Biliary drainage; Rendez-vous; Hepaticogastrostomy; Choledochoduodenostomy
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Core tip: Endoscopic ultrasound-guided biliary drainage (EUS-BD) has recently been
introduced as a valuable approach case in patients with failed endoscopic retrograde
cholangiopancreaticography (ERCP). Evidence suggests that EUS-BD is equally
effective and safer than the percutaneous approach. EUS-BD has even been proposed as
a first-line procedure (replacing ERCP) in selected indications. Various approaches for
EUS-BD exist, depending on the type (malignant or benign) and location (distal or
proximal) of the biliary obstruction, and the anatomy of the upper gastrointestinal tract
(surgically altered or not). This review gives an overview of the technique and the
available data of EUS-BD in several indications.
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INTRODUCTION
E n d o s c o p i c  b i l i a r y  d r a i n a g e ,  a c h i e v e d  b y  e n d o s c o p i c  r e t r o g r a d e
cholangiopancreaticography (ERCP), has been the established first-line therapy for
both benign and malignant  biliary  obstruction since  the  beginning of  the  1990s.
However, even in experienced hands, ERCP fails in 5%-10% of cases[1]  because of
impossible cannulation or inaccessibility of the major papilla (for example due to
tumoral invasion of the ampullary region or surgically altered anatomy). Moreover,
ERCP can be complicated by pancreatitis, cholangitis, bleeding, perforation or stent
dysfunction requiring reintervention[1,2]. Until recently, percutaneous transhepatic
biliary drainage (PTBD) was the only non-surgical  alternative to  achieve biliary
drainage in cases of failed ERCP. However, reported adverse rates of PTBD are high
with 1 out of 4 patients suffering from bleeding, bile leak or acute cholangitis after the
procedure[3].
Endosonographic-guided biliary drainage (EUS-BD) techniques have recently been
introduced as  an alternative to  PTBD.  Over  the last  decade,  increasing operator
experience reduced the number of  adverse events  and augmented technical  and
clinical success rates of EUS-guided biliary drainage. Many retrospective comparative
analyses have concluded that EUS-BD is associated with fewer adverse events as
compared to PTBD and should be the treatment of choice in cases of failed ERCP[4].
EUS-BD might even be considered a first-line approach in patients with distal
malignant bile duct obstruction. Three randomized controlled trials that compared
EUS-BD with ERCP have been published within the last year suggesting that the
success-rate of both techniques is similar, but adverse events and reintervention rates
might be lower for EUS-BD[5-7].  In other words, the “ERCP-first” paradigm is not
sacrosanct, at least for specific indications.
In  this  review,  we describe  the  different  EUS techniques  for  biliary  drainage.
Contemporary evidence regarding the efficacy and safety of EUS-BD in benign as well
as malignant biliary obstructive diseases is discussed. We highlight the comparison
between EUS-BD, PTBD and ERCP. Finally, we provide a practical flowchart that
positions EUS-BD in the current therapeutic algorithm of biliary obstruction and
conclude with some future perspectives.
SEARCH STRATEGY
We searched for relevant publications using PubMed, EMBASE, and the Cochrane
Library, from their inception until Dec 1, 2018. Our search algorithm included the
following  terms:  Endoscopic  ultrasound,  biliary  drainage,  ERCP,  bile  duct,
percutaneous,  rendez-vous,  hepaticogastrostomy,  choledochobulbostomy,
choledochoduodenostomy, hepatico-enterostomy, choledocho-enterostomy in various
combinations. We critically reviewed articles published in English and gave priority
to randomized controlled trials and meta-analyses.
TECHNIQUES
General technique
EUS-guided biliary  drainage  involves  the  visualization  of  dilated  extra-  and or
intrahepatic bile ducts and the puncture of these ducts with a needle or a direct access
device (LAMS). Puncture of dilated left intrahepatic bile ducts is usually performed
from the upper part of the stomach whereas the common bile duct is best accessed
from the bulbar portion of the duodenum. Aspiration of bile confirms the position
within the bile duct. If necessary contrast injection provides cholangiography to plan
the  desired  intervention.  Subsequently,  several  procedures  can  be  performed,
depending on the clinical scenario and the puncture site.
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Rendez-vous technique: This technique is mainly used for benign indications when
retrograde cannulation of the bile duct fails. A prerequisite for the technique is an
endoscopically accessible ampulla or anastomosis. After puncture of the bile duct, a
guidewire  is  advanced  via  the  needle  through  the  ampullary  orifice  into  the
duodenum or  the surgical  anastomosis.  While  this  might  be easy in  some cases,
several challenges may occur. Firstly, with the trans-bulbar approach, the wire may
find its way into the intrahepatic bile ducts rather than the ampulla. This can usually
be overcome by moving to a long scope position, by deflecting the endoscope tip
towards the ampulla or by using a guidewire with an angled tip. Secondly, the wire
may not be able to pass the ampullary orifice (due to a distal stricture, impacted stone,
ampullary stenosis, etc.). In that case, it might be necessary to insert a papillotome
over the wire into the bile duct to further steer and support the wire. Advancement of
a  papillotome  requires  a  prior  cystogastrotomy  using  a  6  Fr  cystogastrotome
(preferred) or 4 mm balloon dilatation. Once transpapillary passage of the wire is
achieved, the wire should be introduced deeply in the duodenum. The needle and the
endoscope are removed leaving the wire in place. Next, a duodenoscope is introduced
to visualize the wire protruding from the ampullary orifice. In most cases it is possible
to cannulate the bile duct next to the wire. Occasionally, the wire needs to be retrieved
using a snare into the endoscope instrument channel. In this way a papillotome can be
introduced over the wire directly in the bile duct.
Choledochoduodenostomy (CDS):  This technique (Figure 1A) is mainly used for
malignant distal bile duct obstruction when the ampulla is not accessible or when
retrograde cannulation fails. It is important to verify duodenal patency beforehand, or
to  place  a  duodenal  stent  or  an  endoscopic  gastrojejunostomy if  indicated.  The
conventional technique involves trans-bulbar puncture of the dilated common bile
duct, then a guidewire is advanced upstream into an intrahepatic bile duct and the
puncture tract is dilated with a cystogastrotome (6 Fr) or a dilation balloon (4 mm).
Thereafter,  a  fully  covered  metallic  stent  can  be  left  in  place  to  achieve  biliary
drainage. Stent migration can be an issue and can be overcome in different ways: By
using a long covered metal stent, a LAMS (AxiosR, Boston Scientific, USA; NagiR stent,
Taewoong Medical, South Korea) or by placing a partially covered stent with the
uncovered portion within the bile duct. However, no short partially covered biliary
stents are available at  the current time (minimal length is currently 8cm with an
uncovered part of 3 cm or 4 cm).
The novel approach involves the use of a LAMS, with direct puncture of the dilated
common bile duct using pure cut current, optional placement of a guidewire and
delivery of the LAMS without a further dilation step. This technique is now favored in
most centers. An 8 mm or 10 mm diameter stent is usually used, and for safe LAMS
placement the diameter of the CBD should exceed 10 mm, to avoid misplacement
Hepaticogastrostomy (HGS): This technique (Figure 1B) can be used for proximal
(perihilar) bile duct obstruction when the ampulla is not accessible, when retrograde
cannulation fails, or when the left lobe cannot be drained by ERCP. It can also be used
for malignant distal bile duct obstruction if the common bile duct is not accessible due
to surgically altered anatomy (e.g.,  after Whipple procedure or roux-en-Y gastric
bypass).  It  is  the  preferred  technique  by  some  experts  in  any  distal  malignant
obstruction. In cases of perihilar bile duct obstruction, this route of drainage can only
drain the left hepatic ducts in case of total hilar obstruction, or both liver lobes in case
of  left-right  biliary communication.  After  puncture,  guidewire  introduction and
dilatation of the puncture tract (using a 6 Fr cystogastrotome or a 4 mm dilatation
balloon), a partially covered stent can be placed, with the uncovered part in the bile
duct to prevent migration and the covered part bridging the bile duct and the gastric
lumen (Giobor stent, Taewoong Medical, South Korea).
In benign diseases, the HGS can be created with a plastic stent to allow for removal,
dilation and sequential repeat access to the bile ducts either for stricture dilatation, or
stone lithotripsy.
EUS-guided antegrade transpapillary stent placement: This technique involves the
same  initial  steps  as  described  above  for  the  rendez-vous  technique  but  after
placement of the guidewire, a metallic stent is advanced through the ampullary orifice
in  an  antegrade  fashion.  This  is  technically  more  challenging  than  EUS-guided
transmural drainage and does not eliminate the risk of pancreatitis.  As such, the
technique should be reserved for patients with benign distal bile duct strictures (e.g.,
in the context of chronic pancreatitis) in whom both the retrograde and rendez-vous
approaches have failed. HGS and antegrade stent placement may be combined.
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Figure 1
Figure 1  Schematic and case illustration of the choledochoduodenostomy (A) and the hepaticogastrostomy
(B). Patient A had a distal bile duct obstruction due to a locally advanced pancreatic head carcinoma. Patient B had a
large perihilar metastasis of a small cell lung carcinoma with a complete obstruction of the proximal common bile duct
but preserved left-right intrahepatic bile duct communication. The choledochoduodenostomy can be combined with a
duodenal stent or an endoscopic gastrojejunostomy if indicated. Adapted from Paik et al[5].
INDICATIONS
Malignant biliary obstructive disease
In 2001, Giovannini et al[8] first reported a successful EUS-guided CDS procedure in a
patient with pancreatic carcinoma and distal malignant biliary obstruction after failed
ERCP. Two years later Burmester et al[9] published a one-step method without the
need  for  switching  from the  ERCP to  the  EUS scope.  This  was  followed by  the
publication of  several  small  case series and studies demonstrating technical  and
clinical feasibility of EUS-guided BD for malignant indications after ERCP failure with
an acceptable safety profile[10-21]. Due to the small size of the individual studies, the
overall efficacy and adverse event profile of EUS-BD had not yet been established. A
meta-analysis  of  Moole  et  al [22]  pooled  16  studies  (until  January  2016,  n  =
528)[13,15,18-20,23-30] and reported a 90.9% success rate for rescue EUS-guided BD with an
overall  procedure related adverse event rate of 16.5%. Khan et  al[31]  showed very
similar results in their meta-analysis that pooled 20 studies (until 2015, n = 1186, 6
studies overlap with Moole et al[22])[21,32-35]. The technical success and post-procedure
adverse event rate were 90% and 17%, respectively. Both meta-analyses included
studies that evaluated EUS-BD both in benign and malignant indications. In Table 1
all  published  case  series  or  studies  investigating  exclusively  malignant  biliary
obstruction are listed (case reports with less than 10 cases are not considered). From
this  table  it  is  evident  that  inclusion  criteria  were  not  homogenous,  different
techniques and materials were used and the definition of technical and clinical success
was diverse. Some studies examined subpopulations such as patients with altered
biliary anatomy[36] or ascites[37]. More recent publications have larger patient cohorts,
but the majority are retrospective and single center[29,37-44]. Khashab et al[45] published a
larger (n = 96), prospective, multicenter study and demonstrated excellent efficacy
and safety of EUS-BD for malignant distal biliary obstruction. It is generally advised
that the procedure should be performed by experts in biliopancreatic endoscopy and
advanced endoscopic ultrasound.
CDS vs HGS: The meta-analysis by Uemura et al[46] in 2018 (10 studies until April
2017,  n  =  434  patients)[21,32,35,44,45,47-51]  did  not  demonstrate  superiority  in  terms of
technical success (CDS: 94.1% vs  HGS: 93.7%) and clinical success (CDS: 88.5% vs
HGS: 84.5%) comparing EUS-CDS and EUS-HGS in patients with malignant biliary
obstruction  (only  2  studies  included  distal  obstruction).  They  also  found  both
procedures  to  be  equivalent  in  terms  of  safety.  This  is  contrary  to  previously
published  studies  that  concluded  EUS-HGS  was  associated  with  more  adverse
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Table 1  Outcome of endoscopic ultrasound-guided biliary drainage
First Author, Yr Type of study Type of malignantobstruction Number patients
Technical
Success rate
ClinicalSuccess
rate Adverse events
Kanno et al[40], 2018 (1) Retrospective,
single center; and (2)
Failed
ERCP/inaccessible
papilla
Unresectable 99 98% 93% Overall: 10%
Rai et al[38], 2018 (1) Retrospective,
single center; and (2)
Failed ERCP or
duodenal
obstruction
(1) Unresectable;
and (2) Distal
30 93.3% 93.3% (1) Overall: 10%; and
(2) 83% stent
patency (3 mo)
Alvarez-Sánchez et
al[37], 2018
(1) Retrospective,
single center; and (2)
Failed ERCP
(1) With/out ascites;
and (2) Distal or
proximal
31; Ascites: 11 100% (1) No ascites: 95%;
and (2) Ascites: 64%
(1) No ascites: 20%;
and (2) Ascites: 9%
Iwashita et al[36],
2017
(1) Prospective,
single center; and (2)
Altered anatomy
Unresectable 20 95% 95% 20%
Minaga et al[52],
2017
(1) Retrospective,
single center; and (2)
Failed ERCP
(1) Unresectable;
and (2) Hilar
obstruction
30 96.7% 75.9% (1) Early: 10%; and
(2) Late: 23.3%
Makmun et al[41],
2017
(1) Retrospective,
single center; and (2)
Failed ERCP
Distal and proximal 24 100% 79.1% 16.7%
Ogura et al[53], 2017 (1) Retrospective,
single center; Failed
ERCP
Hilar obstruction 10 100% 90% 0%
Lu et al[42], 2017 (1) Retrospective,
single center; and (2)
Failed ERCP
Distal and proximal 24 95.8% 100% 13%
Cho et al[51], 2017 (1) Prospective; and
(2) Failed ERCP
54 100% 94.4% 16.6%
Amano et al[48],
2017
Prospective 20 100% 15%
Kunda et al[43], 2016 (1) Retrospective,
single center; and (2)
Failed ERCP
(1) Unresectable;
and (2) Distal
57 98.2% 94.7% 7%
Nakai et al[61], 2016 (1) Retrospective,
multicenter; and (2)
Primary EUS
(1) Unresectable
Distal and proximal
33 100% 100% 9%
Guo et al[44], 2016 (1) Retrospective,
single center; and (2)
Failed ERCP
21 100% 100% 19%
Khashab et al[45],
2016
(1) Prospective,
multicenter; and (2)
Failed ERCP
Distal 96 95.8% 89.5% (1) 10.5%; and (2)
86% stent patency (1
yr)
Ogura et al[49], 2016 Retrospective, single
center
39 (1) CDS: 6%; and (2)
HGS: 2%
Dhir et al[34], 2015 (1) Retrospective,
multicenter; and (2)
Failed ERCP
104 95.% 90.9% 6.8%
Park et al[47], 2015 (1) Prospective,
randomized; and (2)
After failed ERCP
Distal and proximal 22 (1) CDS: 92%; and
(2) HGS: 100%
(1) CDS: 92%; and
(2) HGS: 100%
(1) Early CDS: 25%
vs HGS: 0%; and (2)
Late CDS: 8.3% vs
HGS: 25%
Artifon et al[50],
2015
(1) Prospective,
randomized, single
center; Failed ERCP
Distal 49 (1) CDS: 91%; HGS:
96%
(1) CDS: 77%; HGS:
91%
(1) CDS: 12.5%; and
(2) HGS: 20%
Dhir et al[33], 2014 (1) Retrospective,
multicenter; and (2)
Failed ERCP
Distal and proximal 68 95.6% 20.6%
Kawakubo et al[32],
2014
(1) Retrospective,
multicenter; and (2)
Failed ERCP
Unresectable
Proximal and distal
64 95% 19%
Song et al[21], 2014 (1) Prospective,
single center; and (2)
Failed ERCP
Proximal and distal 27 100% 96.3% 18.5%
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Prachayakul et
al[35], 2013
(1) Retrospective,
single center; and (2)
Failed ERCP
Proximal and distal 22 95.2% 90.5% 9.5%
Hara et al[62], 2013 (1) Prospective ,
single center; and (2)
First line
Distal 18 95% 95% 11%
Khashab et al[45],
2013
(1) Retrospective,
multicenter; and (2)
Failed ERCP
Distal 35 97% 94% 12%
Kim et al[27], 2012 (1) Retrospective,
single center; and (2)
Failed ERCP
Proximal and distal 13 92.3% 91.7%
Iwashita et al[30],
2012
(1) Retrospective,
single center; and (2)
Failed ERCP
40 73% 13%
Song et al[21], 2012 (1) Prospective,
single center; and (2)
Failed ERCP
Distal 15 86.7% 100% 23.1%
Hara et al[19], 2011 (1) Prospective,
single center; and (2)
Failed ERCP
Distal 18 94% 100% 17%
Ramírez-Luna et
al[18], 2011
(1) Prospective,
single center; and (2)
Failed ERCP or PTC
11 91% 90% n = 2
Fabbri et al[16], 2011 (1) Prospective,
single center; and (2)
Failed ERCP
Proximal and distal 16 100% 75% 6.3%
Park et al[11], 2009 (1) Prospective,
single center; and (2)
Failed ERCP
Distal 14 100% 100%
EH: Extrahepatic;  IH:  Intrahepatic;  AG:  Antegrade;  CDS:  Choledochoduodenostomy;  HGS:  Hepaticogastrostomy;  RV:  Rendezvous;  GG:  Gastro-
gallbladder; HES: Hepaticoesophageostomy; SEMS: Self-expandable metal.
events[31,33]. The authors proposed that the choice of approach may be selected based
on patient anatomy and the presence of bile duct dilatation. For example, EUS-CDS is
not suitable for proximal (hilar) biliary obstruction, where an intrahepatic EUS-BD
approach is required. In the specific situation of hilar malignancy EUS-guided HGS
was found to be safe and effective[52,53], although the duration of efficacy was limited[40]
and lower clinical success rates were demonstrated than for distal obstruction[41].
EUS vs PTBD: Two meta-analyses compared EUS-BD and PTBD after failed ERCP or
an inaccessible papilla for malignant biliary obstruction (Table 2). In the meta-analysis
by Moole et al[22], 3 studies were included[34,54,55]. The pooled odds ratio for successful
biliary drainage was higher in EUS-PD versus the PTBD group and the difference for
overall procedure related complications was lower. Other studies found EUS-BD to be
superior[55] or have comparable efficacy[54] with lower[54] or comparable[54] adverse event
rates, need for reintervention and costs. Sharaiha et al[56] included 6 studies[34,54-59] in
their meta-analysis (2 studies were published only in abstract form). There was no
difference in technical success rates between the two procedures but EUS-BD was
associated with better clinical outcomes, fewer post-procedural adverse events and a
lower rate of reintervention. They found no difference in length of hospital stay after
the procedures, but EUS-BD was more cost-effective[4]. In 2018, a retrospective showed
similar results with the additional finding of a shorter hospital stay for EUS-BD[60].
When ERCP fails to achieve biliary drainage, EUS-guided BD seems preferable over
PTBD if the required expertise and logistics are available. The additional advantages
are the avoidance of external drainage catheters and the option of performing the
procedure under the same sedation as the attempted ERCP.
EUS vs ERCP: A limited number of studies reported results for primary EUS-guided
BD without prior ERCP (Table 3). Nakai et al[61] performed EUS-HGS in 33 patients
with gastric outlet obstruction, surgically altered anatomy or history of ERCP-related
adverse events. The procedure appeared safe and effective. These findings have also
been  confirmed  for  primary  EUS-CDS[62].  Kawakubo  et  al[63]  found  comparable
technical success rates with ERCP for EUS-CDS as a first-line treatment for patients
with distal malignant biliary obstruction, and a significantly decreased rate of acute
pancreatitis in the CDS group.
In 2018, the results of 3 prospective, randomized trials comparing primary EUS-
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Table 2  Studies comparing endoscopic ultrasound-guided biliary drainage and percutaneous transhepatic cholangiography
Author, Yr Type of study Type malignantobstruction Number patients
Technical Succes
rate
Clinical Succes
rate
Complications,
EUS vs PTC
Téllez-Ávila et al[60],
2018
(1) Retrospective;
and (2) Failed ERCP
(1) Malignant 56.4%;
and (2) Distal
(1) Total: 62; (2) EUS:
30; and (3) PTC: 32
(1) EUS: 90%; and (2)
PTC: 78.1%
(1) EUS: 96%; and (2)
PTC: 63%
Overall: 6% vs 28.1%
Sportes et al[57],
2017
(1) Retrospective,
multicenter; and (2)
Failed ERCP or
altered anatomy
(1) Unresectable;
and (2) Distal
(1) Total: 51; (2) EUS:
31; and (3) PTC: 20
(1) EUS: 100%; and
(2) PTC: 100%
(1) EUS: 86%; and (2)
PTC: 83%
(1) Overall: 16% vs
10%; and (2)
Reintervention: 6.5%
vs 105%
Lee et al[58], 2016 (1) Randomized,
multicenter; and (2)
Inaccessible papilla
(1) Unresectable;
and (2) Distal
(1) Total: 66; (2) EUS:
34; and (3) PTC: 32
(1) EUS: 94.1%; and
(2) PTC: 96.9%
(1) EUS: 87.5%; and
(2) PTC: 87.1%
(1) Overall: 8.8% vs
31.2%; and (2)
Reintervention: 25%
vs 54.8%
Torres-Ruiz, 2016;
Abstract
Failed ERCP Distal and proximal (1) Total: 66; (2) EUS:
35; and (3) PTC: 31
(1) EUS: 81%; and (2)
PTC: 90.3%
(1) EUS: 90%; and (2)
PTC: 68.7%
(1) Early: 10.8% vs
9%; (2) Late: 16.6%
vs 54%; and (3)
Reintervention: 8.5%
vs 45.1%
Sharaiha et al[56],
2016
(1) Retrospective,
single center; and (2)
Failed ERCP
Malignant: 83.3% (1) Total: 60; (2) EUS:
47; and (3) PTC: 13
(1) EUS: 93.3%; and
(2) PTC: 91.6%
(1) EUS: 62.2%; and
(2) PTC: 25%
(1) Late: 6.6% vs
53.8%; and (2)
Reintervention: 6.6%
vs 53.8%
Bill et al[59], 2015 (1) Retrospective,
single center; and (2)
Failed ERCP
Distal (1) Total: 50; (2) EUS:
25; and (3) PTC: 25
(1) EUS: 76%; and (2)
PTC: 100%
(1) EUS: 96%; and (2)
PTC: 80%
(1) Early: 16% vs
12%; (2) Late: 12% vs
5%; and (3)
Reintervention:
15.8% vs 60%
Giovannini, 2015;
Abstract
(1) Randomized,
multicenter; and (2)
Failed ERCP or
impossible
Malignant: 90.2% (1) Total: 41; (2) EUS:
20; and (3) PTC: 21
(1) EUS: 95%; and (2)
PTC: 100%
(1) EUS: 95%; and (2)
PTC: 85%
Overall: 35% vs 60%
Khashab et al[45],
2015
(1) Retrospective,
multicenter; and (2)
Failed ERCP
Distal (1) Total: 73; (2) EUS:
22; and (3) PTC: 51
(1) EUS: 86.4%; and
(2) PTC: 100%
(1) EUS: 86.4%; and
(2) PTC: 92.2%
(1) Overall: 18.2% vs
39.2%; and (2)
Reintervention:
15.7% vs 80.4%
Bapaye et al[55],
2013
(1) Retrospective,
single center; and (2)
Inaccessible papil
Unresectable (1) Total: 51; (2) EUS:
25; and (3) PTC: 26
(1) EUS: 92%; and (2)
PTC: 46%
(1) EUS: 92%; and (2)
PTC: 46%
Overall: 20% vs 46%
Artifon et al[54],
2012
(1) Prospective,
randomized; and (2)
Failed ERCP
Unresectable (1) Total: 25; (2) EUS:
13; and (3) PTC: 12
(1) CDS: 100%; and
(2) PTC: 100%
(1) CDS: 100%; and
(2) PTC: 100%
Overall: 15.3% vs
25%
EH: Extrahepatic;  IH:  Intrahepatic;  AG:  Antegrade;  CDS:  Choledochoduodenostomy;  HGS:  Hepaticogastrostomy;  RV:  Rendezvous;  GG:  Gastro-
gallbladder; HES: Hepaticoesophageostomy; SEMS: Self-expandable metal stent.
guided BD with ERCP were published. All of them described similar technical success
rates and clinical outcomes. Paik et al[5] found lower rate of adverse events in the EUS-
guided BD group, including post-procedural pancreatitis. This study did not exclude
patients with duodenal obstruction or altered anatomy and also performed EUS-HGS.
The study demonstrated a lower need for reintervention and higher rate of stent
patency in the EUS-guided BD group. The latter finding was attributed to lower risk
of tumor ingrowth and/or overgrowth with transmural stenting bypassing the site of
malignancy[5]. Bang et al[6] and Park et al[7] reported similar rates of adverse events,
reinterventions and stent patency. In the EUS-guided BD group stent occlusion was
commonly caused by migration[63] or food impaction[6]. Paik et al[5] reported that the
median procedure time and length of hospital stay was shorter with EUS-BD. Park et
al[7] found no difference in procedure time between the techniques.
Taking these studies together it would be reasonable to consider EUS-BD as the
primary biliary drainage approach in certain situations where the risk of ERCP failure
or adverse events is substantial.
Benign biliary obstructive disease
The first report on EUS-BD for benign biliary obstructive disease was published in
2005[64].  In  this  report,  a  “neopapilla”  was  created under  endoscopic  ultrasound
guidance near to the original papilla to extract bile duct stones. After this report,
several case series describing the EUS-ERCP rendez-vous technique included patients
with  benign  diseases  such  as  bile  duct  stones  or  ampullary  stenosis[26,65,66].  A
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Table 3  Studies comparing primary endoscopic ultrasound-guided biliary drainage and endoscopic retrograde
cholangiopancreaticography
First Author, Yr Type of study Type malignantobstruction Number patients
Technical
Success rate
ClinicalSucess
rate
Adverse events;
EUS vs ERCP
Paik et al[5], 2018 Prospective
randomized
multicenter
Unresectable; Distal Total: 125; CDS: 32;
HGS: 32; ERCP: 61
EUS: 93.8%; CDS:
90.6%; HGS: 96.9%;
ERCP: 90.2%
EUS: 90.0%; ERCP:
94.5%
Overall: 6.3% vs
19.7%; Pancreatitis:
0% vs 14.8%;
Reintervention:
15.6% vs 42.6%; Stent
patency: 85.1% vs
48.9%
Bang et al[6], 2018 Prospective
randomized single
center
Pancreatic cancer;
Distal
Total: 67; CDS: 33;
ERCP: 34
CDS: 90.9%; ERCP:
94.1%
CDS: 97%; ERCP:
91.2%
Overall: 21.2% vs
14.7%;
Reintervention: 3.0%
vs 2.9%
Park et al[7], 2018 Prospective
randomized single
center
Unresectable;
Extrahepatic; Distal
Total: 30; CDS: 15;
ERCP: 15
CDS: 92.8%; ERCP:
100%
CDS: 100%; ERCP:
92.8%
Overall: 0% vs 0%;
Stent dysfunction:
15.4% vs 30.8%
Kawakubo et al[63],
2016
Retrospective single
center
Distal Total: 82; CDS: 26;
ERCP: 56
CDS: 96.2%; ERCP:
98.2%
Overall: 26.9% vs
35.7%; Pancreatitis:
0% vs 16.1%;
Reintervention (1
yr): 16.6% vs 13.6%
CDS: Choledochoduodenostomy; HGS: Hepaticogastrostomy; SEMS: Self-expandable metal stent.
hepaticogastrostomy has been proposed as a technique to obtain biliary access for
antegrade interventions (stone extraction, dilatation of the bilioenteric anastomosis,
etc.) in patients with surgically altered anatomy (roux-en-y gastric bypass, Whipple
intervention, etc.)[67,68].
COMPLICATIONS
Despite the fact that procedure-related complications of EUS-BD appear to be lower
than for PTBD and potentially also than for ERCP in selected indications (see above),
it remains an invasive procedure with potentially serious adverse events. These may
include  a  pneumoperitoneum  (always  perform  the  procedure  under  CO2
insufflation),  bile  peritonitis,  biliary  gastritis,  haemorrhage,  cholangitis,  stent
obstruction and (life-treatening) stent migration. Procedure-related deaths have been
reported[22,69]. The adverse event rate tends to decrease with the learning curve[22]. For
this reason, we believe that EUS-BD should only be performed in referral centres with
high volume experience in EUS and ERCP.
CONCLUSION
In patients with malignant bile duct obstruction, EUS-BD is a viable option in cases
where ERCP has failed, in the context of surgically altered anatomy or in patients with
an  inaccessible  papilla  due  to  tumoral  invasion.  Based  on  the  results  of  three
randomized studies, EUS-BD might be a reasonable alternative to ERCP as the first-
line procedure in patients with distal malignant bile duct obstruction.
The role of  EUS in establishing biliary drainage where obstruction is  due to a
benign aetiology is rather limited (less than 5% in most case series)[22]. A rendez-vous
approach can be particularly useful in patients with an accessible duodenum in whom
the papilla cannot be identified or cannulated (e.g., in the case of a large duodenal
diverticulum). Temporary transmural drainage with a choledochoduodenostomy or
hepaticogastrostomy and subsequent antegrade treatment after the fistula tract has
matured has been described (especially in patients  with altered anatomy due to
previous surgery) but should be reserved for cases in which less invasive alternatives
have failed.
In Figure 2, we propose a practical flowchart that suggests roles for EUS-BD within
the current management algorithm of benign and malignant biliary obstruction.
Given the development of EUS-BD over the last few years, it is anticipated that
novel dedicated endoscopic devices and tools will be released. New LAMS allowing
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Figure 2
Figure 2  Proposed algorithm that positions endoscopic ultrasound-guided biliary drainage in the current management of biliary obstructive disease. *The
choledochoduodenostomy can be combined with a duodenal stent or an endoscopic gastrojejunostomy if indicated. CDS: Choledochoduodenostomy; HGS:
Hepaticogastrostomy; ERCP: Endoscopic retrograde cholangiopancreaticography.
puncture,  tract  dilatation  and  stent  delivery  in  one  step,  provide  significant
advantages  over  needle/guidewire/dilation  and  stent  delivery  techniques.  A
steerable  wire  specifically  designed  for  EUS-BD  is  being  developed  (oral
communication, Boston Scientific, Massachusetts, USA). A 4 cm partially covered
stent for CDS is expected mid 2019 (oral communication, Taewoong Medical, South
Korea). A one-step dedicated stent introducer with a push-type dilator without the
need for pre-dilatation or use of electrocautery has recently been described and will,
when  it  becomes  available,  further  facilitate  EUS-guided  transmural  biliary
drainage[5].
Future studies should address whether EUS-BD should be the first-line therapy
(rather than ERCP or PTBD) in patients with malignant bile duct obstruction with
preserved left-right intrahepatic bile duct communication.
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